Riskpilot← Back to searchSign inGet full accessNordic-Neurostim ApS
APSActiveCVR 38049909Thorndahlsvej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 2016— employeeswww.nordicneurostim.com
Revenue 2024
DKK 196K
-932% vs 2023
EBITDA margin
100.0%
+932% vs 2023
Equity ratio
-207.8%
Financial strength
Net profit 2024
DKK -10K
+93% vs 2023
| Revenue | DKK 196K | -932% |
| EBITDA | DKK 196K | +932% |
| Net profit | DKK -10K | +93% |
| Total assets | DKK 878K | -6% |
| Equity | DKK -1,8M | -1% |
| Employees | — | — |
Legal name
Nordic-Neurostim ApS
CVR number
38049909
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28. september 2016
Share capital
DKK 57.918
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling, forskning, markedsføring og salg af produktet Incedo, som er medicinsk udstyr til behandling af Stroke-patienter ved brug af reflex-baseret gang-genoptræning samt andre lignende aktiviteter.
Address
Thorndahlsvej 3
Phone
+4531561520
Email
cc@nordicneurostim.com
Website
www.nordicneurostim.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -1.063 | -1.390 | -562 | -24 | 196 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1.063 | -1.390 | -562 | -24 | 196 |
| Depreciation & amort. | -35 | -35 | -35 | -35 | -0 |
| EBIT | -1.097 | -1.425 | -596 | -58 | 196 |
| Net financials | -73 | -89 | -108 | -189 | -209 |
| Profit before tax | -1.171 | -1.513 | -704 | -247 | -13 |
| Tax | -244 | -415 | -250 | -98 | -3 |
| Net profit | -927 | -1.098 | -454 | -149 | -10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.658 | 1.608 | 1.337 | 937 | 878 |
| Equity | -113 | -1.212 | -1.666 | -1.815 | -1.825 |
| Long-term debt | 1.000 | 2.076 | 2.177 | 2.257 | 2.260 |
| Short-term debt | 772 | 744 | 827 | 494 | 443 |
| Total debt | 1.772 | 2.820 | 3.004 | 2.751 | 2.703 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
-207.8%
This company
38.2%
Market median
-644% vs market
20202024
Return on equity
-1026400.0%
This company
18.4%
Market median
-5578361% vs market
20202024
Net profit margin
-5.2%
This company
8.1%
Market median
-164% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CP Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2020 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 | |
| Company | 5–9.99% | 5–9.99% | 2024 | |
| Company | 5–9.99% | 5–9.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MORTEN HAUGLAND HOLDING ApS
Nordic-Neurostim ApS Board members of Nordic-Neurostim ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Peter Christiansen | Chief Executive Officer | 0 companies |
| Morten Kristian Haugland | Chairman | 0 companies |
| Henrik Kähler | Board of Directors | 0 companies |